Presentation TCT 2017 When Should Coronary Disease Be Suspected and Worked Up in Hypertension? Presenter: Mark C. Bates, Bernard J. Gersh, Farrell O. Mendelsohn October 30, 2017
Presentation TCT 2017 Why Are Hypertension and Coronary Artery Disease So Connected? Presenter: Mark C. Bates, Bernard J. Gersh, Suzanne Oparil October 30, 2017
Presentation TCT 2017 Renal Artery Atherosclerosis and Secondary Hypertension: Frequency, Diagnosis, and Treatment Presenter: Mark C. Bates, Bernard J. Gersh, Michael R. Jaff October 30, 2017
Presentation CDM 2017 Transitiong From a CAD to Peripheral Vascular Disease Practice Presenter: Terry R. Bowers October 05, 2017
Presentation SCAI 2017 The Atherosclerosis Risk in Communities (ARIC) Surveillance Study Presenter: Sameer Arora May 13, 2017
Presentation ACC 2017 Results of the CARAT Study: Effect of Serial Infusions of CER-001, a Pre-Beta High-Density Lipoprotein Mimetic on Coronary Atherosclerosis Presenter: Stephen J Nicholls March 20, 2017
Presentation Miami Valves 2017 Coronary Physiology and New Technology in the Heavily Reported Environment Presenter: Michael Dyal January 29, 2017
Presentation TCT 2016 Stenting for Intracranial Atherosclerosis: Who, When, and How Presenter: D. Christopher Metzger, Bernhard Reimers, Alex Abou-Chebl November 01, 2016
Presentation TCT 2016 TCT 598: Plaque Rupture in Coronary Atherosclerosis is Associated with Increased Plaque Structural Stress Presenter: Eric Boersma, James E. Muller November 01, 2016
Presentation TCT 2016 CKD, Atherosclerosis, and Vascular Calcification: Essentials for the Interventionalist Presenter: Somjot S. Brar, Richard Solomon, Anand Prasad November 01, 2016
Presentation TCT 2016 Clinical Importance and Metrics of the Microcirculation in Patients With Atherosclerosis Presenter: Javier Escaned, Amir Lerman, Keith G. Oldroyd October 31, 2016
Presentation TCT 2016 TCT 96: Progression of Coronary Atherosclerosis Despite Lipid-Lowering Therapy in Diabetic Patients Compared to Non-Diabetic Ones. Study With 3D Intravascular Ultrasound and Virtual Histology Presenter: Farouc Jaffer, Amir Lerman, Tomas Kovarnik October 31, 2016
Presentation TCT 2016 Anti-inflammatory Therapies for Atherosclerosis Presenter: Robert A. Harrington, A. Michael Lincoff, Jean-Claude Tardif October 30, 2016
Presentation Ambient Air Pollution Is Associated With the Severity of Coronary Atherosclerosis and Incident MI in Patients Undergoing Elective Cardiac Evaluation Presenter: J. Hartiala August 03, 2016
Presentation Fellows 2016 Atherosclerosis, Vulnerable Plaque, and How We Evaluate Devices in the Preclinical Setting Presenter: Kevin Croce April 15, 2016
Presentation TCT 2015 Will PCSK9 Inhibitors Transform the Natural History of Atherosclerosis? Presenter: Gregg W. Stone, Renu Virmani, Philippe Gabriel Steg October 12, 2015
Presentation Fellows 2015 Atherosclerosis, Vulnerable Plaque, and How We Evaluate Devices in the Preclinical Setting Presenter: Ajay J. Kirtane, Mauricio G. Cohen, Greg L. Kaluza May 15, 2015
Presentation ADAPT-DES Substudy: Effect of Obesity on Coronary Atherosclerosis and Outcomes of PCI Presenter: S.J. Kang January 20, 2015
Presentation TCT 2014 Atherosclerosis and Vascular Disease Over the Millennia: Whats the Connection with AAA Disease? Presenter: Frank J. Criado, Christopher K. Zarins, Robert A. Lookstein September 16, 2014
Presentation TCT 2014 TCT 345: Distribution of Excessive Expansive Remodeling and Low Endothelial Shear Stress in the Long Axis of Human Coronary Plaque and Their Combined Effects on the Natural History of Atherosclerosis Presenter: Charles J. Davidson, Robert J. Russo, Ryan D. Madder, Antonios Antoniadis September 15, 2014